Skip to main content
. 2020 Jul 23;10(3):e137. doi: 10.1002/ctm2.137

FIGURE 2.

FIGURE 2

Comparison of recurrence rates and OS between CTC‐stratified HCC patients in TACE and control groups before PSM. Recurrence rates (A) and OS (B) for CTC‐negative patients in TACE and control groups before PSM. Recurrence rates (C) and OS (D) for CTC‐positive patients in TACE and control groups before PSM